The Global Push for Mechanical Thrombectomy in Stroke Care
Increasing the use and accessibility of mechanical thrombectomy may reduce the burden of stroke on a global scale.
RGMa Inhibition for Repair and Protection in Multiple Sclerosis
Patients with MS have an urgent need for therapies that can reverse neurologic disability by promoting remyelination, and RGMa inhibition may help meet that need.
Data Evolution in Alzheimer Disease: Is the Future Digital?
Digital biomarkers offer promise to revolutionize the diagnosis and treatment of Alzheimer disease via our increasing ability to gather active and passive data.
Updates in Approaches to Acute Migraine Care
In a NeurologyLive® Peer Exchange, a panel of migraine specialists discussed the novel therapies in development and those entering the market for the treatment of acute migraine.
Recent Advances in the Understanding of Insomnia
Guest Editor-in-Chief Karl Doghramji, MD, FAASM, DFAPA, discusses the recent steps forward that have been made in the care of patients with insomnia.
Eisai Targets Dravet Syndrome Indication for Lorcaserin With Multifaceted Study Design
A Team Approach to Asleep Deep Brain Stimulation
Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.
Sleep Deprivation Among Frontline Health Care Workers During COVID-19 Turns Critical
The pandemic's impact stretches across all aspects of life, and has particularly concerning effects on the sleep of those working on the frontlines providing care of patients.
2 Commerce Drive Cranbury, NJ 08512